Recursion Pharmaceuticals is harnesing the power of artificial intelligence to rapidly develop new drugs. The drugmaker's former lead candidate failed to show evidence of efficacy in a phase 2 ...

Dave Bautista and Milla Jovovich star in an incoherent adaptation of an old Martin story about witches and werewolves.

After hours: March 7 at 7:59:38 PM EST Loading Chart for RXRX ...

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

Machine-learning techniques keep improving efficiency in one industry after another. One corner of the economy where investors expect another big leap forward is the world of drug development.

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ: RXRX). The company has emerged as a ...

Kara takes the winning Standard deck from Pro Tour Aetherdrift and converts it into a Commander deck in the latest 60 to 100.

Genomics has long been a primary focus in precision medicine, but other areas of research are increasingly being used to help ...

After hours: March 7 at 7:59:36 PM EST Loading Chart for CRSP ...